TheraRadar
← Back
Data updated: Mar 29, 2026

ANTHEA PHARMA

CardiovascularMetabolic
Generics

ANTHEA PHARMA is a generic drug manufacturer focused on Cardiovascular, Metabolic.

2025
Since
5
Drugs
-
Trials
71
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

LACOSAMIDE 2026-01-29
LACOSAMIDE 2026-01-21
SODIUM BICARBONATE 2026-01-13
NOREPINEPHRINE BITARTRATE 2025-12-11
NOREPINEPHRINE BITARTRATE 2025-11-25
LACOSAMIDE 2025-10-15
Labeling
LACOSAMIDE 2025-10-15
Labeling
LACOSAMIDE 2025-10-15
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 50%
1 drugs
Metabolic 50%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Merck big-pharma
Cardiovascular, Metabolic
Johnson & Johnson big-pharma
Cardiovascular, Metabolic
Bayer big-pharma
Cardiovascular, Metabolic
B BRAUN specialty
Metabolic, Cardiovascular
AstraZeneca big-pharma
Cardiovascular, Metabolic